相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiation Dosimetry in Lu-177-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Andreas Rinscheid et al.
EJNMMI PHYSICS (2020)
Characterization of Noise and Resolution for Quantitative 177Lu SPECT/CT with xSPECT Quant
Johannes Tran-Gia et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study
Wei Zhao et al.
PHYSICS IN MEDICINE AND BIOLOGY (2019)
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu-PSMA therapy
Andreas Rinscheid et al.
MEDICAL PHYSICS (2019)
Dose Mapping After Endoradiotherapy with Lu-177-DOTATATE/DOTATOC by a Single Measurement After 4 Days
Heribert Haenscheid et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Technical Note: Single time point dose estimate for exponential clearance
Mark T. Madsen et al.
MEDICAL PHYSICS (2018)
Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance
Mattias Sandstrom et al.
ACTA ONCOLOGICA (2018)
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
Michela Del Prete et al.
EJNMMI PHYSICS (2018)
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
Anna Sundlov et al.
EJNMMI PHYSICS (2018)
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (Lutate') therapy
Kathy P. Willowson et al.
EJNMMI PHYSICS (2018)
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Anna Sundlov et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative Lu-177 SPECT Applied for Dosimetry of Radiopharmaceutical Therapy
Michael Ljungberg et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment
Jorma Heikkonen et al.
ACTA ONCOLOGICA (2016)
The Influence of Early Measurements Onto the Estimated Kidney Dose in [177Lu][DOTA0,Tyr3]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors
Andreas Delker et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy
Johan Gustafsson et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Kidney Dosimetry in Lu-177 and Y-90 Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
F. Guerriero et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Prediction of Therapy Tumor-Absorbed Dose Estimates in I-131 Radioimmunotherapy Using Tracer Data Via a Mixed-Model Fit to Time Activity
Matthew J. Schipper et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Accuracy and optimal timing of activity measurements in estimating the absorbed dose of radioiodine in the treatment of Graves' disease
S. Merrill et al.
PHYSICS IN MEDICINE AND BIOLOGY (2011)
分享论文
